IRIS
IEZZI, MANUELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.681
EU - Europa 2.960
AS - Asia 1.400
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 6
AF - Africa 3
OC - Oceania 3
Totale 8.066
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.673
CN - Cina 657
UA - Ucraina 597
IT - Italia 484
SE - Svezia 484
TR - Turchia 455
GB - Regno Unito 356
IE - Irlanda 283
FR - Francia 242
IN - India 229
DE - Germania 211
BE - Belgio 135
FI - Finlandia 120
VN - Vietnam 31
RU - Federazione Russa 14
IR - Iran 13
EU - Europa 12
GR - Grecia 7
NL - Olanda 6
CA - Canada 5
CZ - Repubblica Ceca 4
IL - Israele 4
RO - Romania 4
AT - Austria 3
CH - Svizzera 3
CL - Cile 3
MY - Malesia 3
BR - Brasile 2
JP - Giappone 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BG - Bulgaria 1
CY - Cipro 1
EG - Egitto 1
ES - Italia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
SG - Singapore 1
SN - Senegal 1
Totale 8.066
Salva come PNG Salva come JPEG
Città #
Chandler 910
Jacksonville 704
Princeton 300
Southend 286
Dublin 281
Dearborn 233
Izmir 224
Nanjing 183
Ann Arbor 155
Beijing 146
Altamura 134
Wilmington 134
Brussels 131
Chieti 112
Cambridge 111
Boardman 83
Ashburn 66
Nanchang 63
Woodbridge 50
Hebei 34
Grevenbroich 33
Dong Ket 31
Washington 30
Shenyang 29
Tianjin 29
Helsinki 27
Kunming 24
Norwalk 23
Changsha 21
Rome 20
Jiaxing 18
Hangzhou 16
San Mateo 16
Augusta 14
Jinan 14
Orange 14
Falls Church 13
Houston 12
Pescara 12
Leawood 11
Milan 10
Ardabil 9
Changchun 9
Lanzhou 9
Napoli 9
Guangzhou 8
Hefei 8
Collecorvino 7
Lanciano 7
London 7
Chicago 6
L’Aquila 6
Rouen 6
Saint-Saens 6
Taizhou 6
Monmouth Junction 5
San Giovanni 5
Tappahannock 5
Torino 5
Toronto 5
Zhengzhou 5
Andover 4
Bari 4
Frankfurt am Main 4
Fuzhou 4
Jülich 4
L'aquila 4
Palermo 4
Redwood City 4
Auburn Hills 3
Brno 3
Cachan 3
Castelletto Stura 3
Ferrara 3
Haikou 3
Kuala Lumpur 3
Mcallen 3
Naples 3
Nereto 3
Ningbo 3
Redmond 3
Vienna 3
Amsterdam 2
Baotou 2
Catania 2
Cattolica 2
Chongqing 2
Civitella Del Tronto 2
Edinburgh 2
Los Angeles 2
Mountain View 2
Munich 2
Novokuznetsk 2
Ougree 2
Quzhou 2
Rio de Janeiro 2
Saint-Fons 2
Salerno 2
Seattle 2
Shanghai 2
Totale 4.997
Salva come PNG Salva come JPEG
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 114
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. 104
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 99
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 90
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 86
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 84
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 83
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 82
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 82
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 82
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 81
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 81
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 79
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 79
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 79
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 79
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 78
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 78
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 77
Anti-Thyroid Effect of Resveratrol 77
null 77
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 76
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 76
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 75
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 75
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 73
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 73
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 72
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 72
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 72
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 72
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 72
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 71
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 71
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 71
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 70
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 70
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 70
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 70
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 69
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 69
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 67
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 67
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 67
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 67
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 67
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 67
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 67
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 67
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 66
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 66
Neutrophils in anti-cancer immunological strategies: old players in new games 66
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 66
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 66
Inhibition of the Phosphatidylinositol 3-kinase/Akt Pathway by Inositol Pentakisphosphate Results in Antiangiogenic and Antitumor Effects. 66
Stem Cell Emergence After HBO In Volunteers 65
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 65
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 65
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 64
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 64
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 64
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 64
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 64
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 63
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 63
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 62
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 62
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 62
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 62
p130Cas is an essential transducer element in ErbB2 transformation. 61
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 60
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 60
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 60
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 59
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 59
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 58
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 58
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 58
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 58
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 58
null 58
Phospholipase Cgamma1 is required for metastasis development and progression 57
Intramammary application of non-methylated-CpG oligodeoxynucleotides (CpG) inhibits both local and systemic mammary carcinogenesis in female BALB/c Her-2/neu transgenic mice. 57
Triggering CD40 on endothelial cells contributes to tumor growth. 57
Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma. 57
Antimetastatic activity of a preventive cancer vaccine. 57
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 57
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer 57
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 57
Host perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma. 56
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 56
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 56
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 55
Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance. 55
Mesenchymal/Stromal Gene Expression Signature Relates to Basal-Like Breast Cancers, Identifies Bone Metastasis and Predicts Resistance to Therapies 54
The Human Splice Variant Δ16HER2 Induces Rapid Tumor Onset in a Reporter Transgenic Mouse. 54
Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer 54
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 53
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 53
Immune prevention of mammary carcinogenesis in HER-2/neu transgenic mice: a microarray scenario. 51
Totale 6.791
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019449 0 0 0 0 0 25 104 19 18 5 12 266
2019/20201.749 474 122 10 60 147 160 227 148 55 157 166 23
2020/2021932 135 17 150 12 88 165 27 10 58 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.568 184 364 158 288 274 476 153 186 294 43 76 72
2023/2024430 90 97 73 64 88 18 0 0 0 0 0 0
Totale 8.586